Mirae Asset Global Investments’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50.8K Buy
3,431
+462
+16% +$6.84K ﹤0.01% 1252
2025
Q1
$58.4K Buy
2,969
+108
+4% +$2.13K ﹤0.01% 1211
2024
Q4
$49.4K Buy
2,861
+94
+3% +$1.62K ﹤0.01% 1267
2024
Q3
$38.8K Buy
2,767
+494
+22% +$6.92K ﹤0.01% 1345
2024
Q2
$18.8K Sell
2,273
-47,905
-95% -$397K ﹤0.01% 1386
2024
Q1
$804K Buy
50,178
+3,754
+8% +$60.2K ﹤0.01% 1651
2023
Q4
$417K Buy
46,424
+3,083
+7% +$27.7K ﹤0.01% 2054
2023
Q3
$387K Sell
43,341
-5,326
-11% -$47.6K ﹤0.01% 2011
2023
Q2
$747K Buy
48,667
+4,767
+11% +$73.1K ﹤0.01% 1748
2023
Q1
$987K Buy
43,900
+12,340
+39% +$278K ﹤0.01% 1556
2022
Q4
$664K Buy
31,560
+28
+0.1% +$589 ﹤0.01% 1726
2022
Q3
$777K Buy
31,532
+12,290
+64% +$303K ﹤0.01% 1623
2022
Q2
$466K Buy
+19,242
New +$466K ﹤0.01% 1784